JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A4448 Actinomycin D
52 Citation

Summary: RNA polymerase inhibitor

≥62.75 mg/mL
A1042 Angiotensin II
21 Citation

Summary: Potent vasopressor and GPCR agonist

≥234.6 mg/mL
B2136 Zanamivir

Target: Influenza viruses

Summary: Influenza A/B virus neuraminidases inhibitor

insoluble in DMSO; insoluble in EtOH; ≥8.99 mg/mL
A4394 Docetaxel
9 Citation

Summary: Microtubulin disassembly inhibitor

≥40.4 mg/mL
B1293 Y-27632
37 Citation

Target: ROCK

Summary: ROCK inhibitor

≥24.7 mg/mL
A8192 Staurosporine
20 Citation

Summary: serine/threonine protein kinases inhibitor

insoluble in H2O; insoluble in EtOH; ≥11.66 mg/mL
A3847 SU5416
7 Citation

Target: VEGFR

Summary: VEGFR2 inhibitor

insoluble in EtOH; insoluble in H2O; ≥11.9 mg/mL
A3007 ABT-263 (Navitoclax)
57 Citation

Target: Bcl-2|Bcl-w

Summary: Bcl-2 family inhibitor

≥48.73 mg/mL
A2587 PMSF
14 Citation

Target: Serine Proteases

Summary: PMSF

insoluble in H2O; ≥17.4 mg/mL
A1901 Q-VD-OPh
83 Citation

Target: Caspases

Summary: pan-caspase inhibitor

≥25.67 mg/mL